<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-5IPW2NTN</identifier><date>2016</date><creator>Jošt, Maja</creator><relation>documents/doc/5/URN_NBN_SI_doc-5IPW2NTN_001.pdf</relation><relation>documents/doc/5/URN_NBN_SI_doc-5IPW2NTN_001.txt</relation><format format_type="issue">2/3</format><format format_type="volume">67</format><format format_type="type">article</format><format format_type="extent">str. 159-166</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID">285188096</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-5IPW2NTN</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">ledvična funkcija</subject><subject language_type_id="slv">mišični simptomi</subject><subject language_type_id="slv">presnovni sindrom</subject><subject language_type_id="slv">statini</subject><title>Optimizacija zdravljenja z nekaterimi zdravili v sklopu metaboličnega sindroma</title><title>Optimization of the treatment with certain medecations in metabolic syndrome</title></Record>